ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -20 مورد

Approach to benign prostatic hyperplasia (BPH) management

Approach to benign prostatic hyperplasia (BPH) management
This algorithm summarizes an approach to the treatment of BPH. Prior to initiating treatment, patients should be evaluated for LUTS etiology to confirm that symptoms are due to BPH. Please refer to related UpToDate content for further details.

5ARI: 5-alpha reductase inhibitors; CT: computed tomography; DRE: digital rectal exam; LUTS: lower urinary tract symptoms; MRI: magnetic resonance imaging; PSA: prostate-specific antigen; TRUS: transrectal ultrasonography.

* A PSA of ≥4 ng/mL is a widely accepted cutoff value; however, no single PSA value avoids both false positives and missing important cancers at a curable stage.

¶ Lifestyle modifications include limiting fluid intake and maintaining physical activity; behavioral modifications include timed voiding and double voiding.

Δ Symptom severity is assessed using the American Urological Association urinary symptom score/International Prostate Symptom Score and the patient's perception of impact on quality of life. Please refer to related UpToDate content for a related scoresheet and calculator.

◊ Prostate size may be estimated with TRUS, MRI, or CT. MRI or CT are not indicated solely to determine medical therapy. Instead, previous imaging results from the last 2 years or imaging for another indication may be used to estimate prostate size.

§ Surgery is a reasonable alternative to medical therapy in patients with contraindications to medications, in patients who prefer not to take medications, and as second-line treatment for patients whose symptoms are refractory to medical therapy. Please refer to related UpToDate content for further details.

Graphic 146391 Version 1.0